source
- Parabilis raises $670M in record-setting Nasdaq debut to fund cancer drug developmentParabilis completed a $670 million initial public offering on the Nasdaq, establishing the largest biotech debut in the exchange’s history. The offering drew strong investor demand even as attenti…
- Parabilis raises record $670 million in biotech IPO, the largest for a venture-backed companyParabilis Medicines, a biotech focused on "undruggable" targets, completed an initial public offering that raised $670 million, the biggest amount ever for a venture-backed biotech. The company so…